article thumbnail

Reality Bites: Disappointment in the R&D Sector

Pharmaceutical Technology

This is confirmed by the Centre for Medicines Research International which shows in 2004 that more than 20% of the money invested in R&D by ten of the largest pharmaceutical companies went on line extensions, as opposed to new development projects. %, while R&D accounts for just 17.1% “It’s very disappointing.